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THE  INTERACTION OF HERPES SIMPLEX  VIRUS 
WITH MURINE LYMPHOCYTES 
I.  Mitogenic Properties of Herpes Simplex Virus* 
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Many acute viral  diseases  can be contained by vaccination,  however, there 
exist  a number of  slow, latent,  and chronic viral  diseases  for which such con- 
trol is not possible.  Such viruses exhibit a number of relationships  with the 
host cell.  They may replicate  so slowly they are undetectable in the host cell, 
or  they may be replicated  with the host genome. The mechanisms by which the 
expression of  the host cell  genome and the viral  genome influence  each other 
are unknown and they form a unique area of  eukaryotic gene regulation. 
Herpes simplex viruses (HSV)  I cause many common  diseases in humans. 
There are two major serotypes of HSV, designated type 1 and type 2 (1, 2). 
HSV-1 is associated  with recurrent fever  blisters,  while HSV-2 is  closely  asso- 
ciated with venereal diseases. The two serotypes show minor differences  in 
several biological,  physical,  and immunological properties,  however, only 20- 
30% of  their  DNA  sequences are held in common (3).  Interest  in the oncogenic 
potential of HSV  originates primarily from the suspected role of another 
Herpes group virus  in several human malignancies, especially  Burkitt's  lym- 
phoma and nasopharyngeal carcinomas (for  review see 4, 5). The oncogenic 
potential of HSV  has been demonstrated by morphological transformation of 
cells  in  human, hamster, and mouse fibroblast  cultures  and  by  tumor formation 
in animals (6-10).  Target cell  transformation is observed only after  the inacti- 
vation of infectious  HSV  by ultraviolet  irradiation (6-10)  which reduces the 
lytic  activity  of  HSV, and the HSV-transformed cells  appear to  propagate only 
fragments of  the original  HSV genome (11,  12). 
Infection  of  both  humans and mice with HSV is  followed  by  the  disappearance 
of virus, and  sustained latent viral infections are later manifest  by the 
reappearance of  infectious  virus  (13).  A major problem in studying the expres- 
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sion of the oncogenic potential or latency of HSV is to find cells that can be 
infected with virus in culture and then undergo cell transformation without 
being  destroyed  by  virus  replication.  In  other  words,  host  cells  that  are 
nonpermissive  for  virus  replication,  but  permissive  for  the  expression  of 
transformation genes, are not available. In this report we describe the effects 
of infectious HSV in mouse spleen cultures. 
Materials and Methods 
Mice.  C57BL/6J  and  C3H/HeJ  mice  were  purchased  from  The  Jackson  Laboratory,  Bar 
Harbor, Maine. BALB/c mice were obtained from Strong Laboratories, Del Mar, Calif. Congeni- 
tally athymic (nu/nu) and heterozygons (nu/+) mice were from our breeding colony (14). 
Spleen Cultures.  Mouse spleen cells were prepared  as described elsewhere (15).  Cells were 
resuspended at a  density of 5  ×  10  e cells/ml in Eagles medium (Gibco F-14) supplemented with 
5% fetal calf serum (Irvine Scientific, Irvine, Calif.), 10  -5 M 2-mercaptoethanol, i mM glutamine, 
and antibiotics (15). Aliquots of 0.2 ml (106 cells) were plated into each well of a  microtitre plate 
(Microtest II, Falcon Plastics, Division of BioQuest, Oxnard,  Calif.) and incubated at 37°C in a 
gas mixture of 7% oxygen, 10% carbon dioxide, and 83% nitrogen. Control cultures were treated 
with Escherichia  coli K235 LPS (generously provided by Abbott Laboratories,  N. Chicago, Ill.). 
After 24,  48, 72,  or 96 h, cultures were radioactively-labeled for 6 h  with 0.5 ~Ci [SH]thymidine 
(12 c/mmol, New England Nuclear, Boston, Mass.) and harvested with the Mash II (Microbiolog- 
ical Associates, Bethesda,  Md.) harvester. 
Spleen  cultures  were  depleted  of macrophages  by  using  Sephadex  G-10  (16).  Polyclonal 
antibody responses were determined with a  microscope slide assay (17),  in which sheep erythro- 
cytes (SRBC)  (Colorado Serum Co.,  Denver, Colo.), or TNP-SRBC were used as indicator cells 
(18).  The difference in the number of PFC determined with SRBC and TNP-SRBC as indicator 
cells yields the number of TNP-specific PFC present. 
Cell and Viruses.  The HSV-1 strains used in this study were either primary isolates made in 
this  laboratory  (Muckbeck,  JH)  or were obtained  from  Dr.  Berge Hampar  (Nil,  Savage).  All 
virus stocks were prepared on diploid human foreskin fibroblasts originating in this laboratory. 
The cells were propagated  in complete MEM containing 5% fetal calf serum  and gentamycin. 
The cells were mycoplasma free and used a passage level of less than 10 from the primary culture. 
Virus stocks were prepared by infection at a  multiplicity of 0.1 plaque-forming unit  (PFU)/cell 
followed by incubation at 37°C for 48-60 h. Aider this incubation,  the cell debris were removed 
from the culture supernate by centrifugation and the resulting fluid used without further treat- 
ment. Only extracellular virus was used in these studies. 
Results 
Mitogenic Responses  to HSV.  The data presented in Fig. 1 show the effect 
of different concentrations of infectious HSV-1  (Muckbeck) on DNA synthesis 
in BALB/c spleen cultures. Three points should be emphasized. First, HSV-1 
stimulates DNA synthesis, optimal responses being observed with 5  x  106 to 
106  PFU/culture  (Fig.  1).  Second, when cultures are  assayed for polyclonal 
antibody  responses  to  TNP  determinants,  an  increase  in  PFC  specific  for 
TNP is observed (Fig.  1). Third, with an optimum concentration of HSV-1, a 
kinetic analysis of the DNA synthetic responses show a peak is reached after 
48 h, and thereafter decreases (Fig. 2). Similar results have been obtained by 
using four other isolates of HSV-1, JH, Nil, and Savage, (data not presented). 
Under optimal conditions, the stimulation index in both the DNA and poly- 
clonal responses, ranges in our experiments from 10- to 50-fold. 
The data presented in Fig. 3 show the effect of HSV-1 (JH) on DNA synthesis 
in normal, T-cell-depleted, and macrophage-depleted spleen cultures,  and in 1502  MITOGENIC  RESPONSE  OF  MURINE  B  CELLS 
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Fro.  1.  The effect of HSV-1  (Muckbeck) on DNA synthesis in BALB/c spleen cultures. 
Each culture contained 106 spleen cells in 0.2 ml medium and the titer of virus indicated. 
Alter 48 h, cultures were labeled with 0.5 ~Ci [3H]thymidine for 6 h, and then harvested. 
Each point represents the mean of quadruplicate cultures. The polyclonal responses were 
assayed after 72 h  in culture. Quadruplicate cultures were harvested and assayed for PFC 
directed against SRBC  or SRBC conjugated with TNP,  by using a  modified Jerne assay 
(17).  The difference between SRBC-PFC and TNP-SRBC-specific PFC gives the number of 
TNP-PFC,  which serves as the indicator of a  polyclonal antibody response.  Each figure 
represents the mean of quadruplicate microcultures. 
thymocyte cultures. The stimulation of DNA synthesis was similar in both 
normal and T-cell-depleted (nu/nu) spleen cultures (Fig.  3),  however, HSV-1 
does not stimulate DNA synthesis in thymocyte cultures. Removal of macro- 
phages by passaging through Sephadex G-10 columns (16), had little effect on 
the DNA synthesis response to HSV-1  (Fig.  3). As a control, we also describe 
the response of these various cultures to 0.5 ~g E. coli K235 LPS (Fig. 3). Since 
HSV-1  and  LPS  stimulated  DNA  synthesis in  normal,  T-cell-depleted and 
macrophage-depleted  cultures, but not in thymocyte  cultures, the cells respond- 
ing to HSV-1 appear to be the B lymphocytes. Since polyclonal responses are 
also  observed in  these  cultures  (Fig.  1),  we consider the  target cell  the  B 
lymphocyte. 
Nature of  DNA Synthesis.  The addition of infectious HSV to spleen cultures 
could result in either viral DNA replication, or host cell DNA synthesis. Since 
HSV  DNA  and  mouse  DNA  have  different densities,  they  can  be  easily 
separated by equilibrium sedimentation (2). Experiments were performed to 
determine whether the DNA synthesized in spleen cultures treated with HSV 
was viral or cellular in origin.  Spleen cultures were prepared from BALB/c 
mice and incubated with 5 ;tg/ml K235 LPS as a  control, or 5  ×  106 PFU/ml 
HSV-1 (Nii).  After 48 h, 1.25 ~Ci [~H]thymidine was added to cultures for 6 h, 
then DNA was separately prepared from each culture. The DNA was examined 
by  cesium chloride density sedimentation.  As  a  marker for  HSV  DNA,  a 
sample  of 32P-labeled Pseudomonas  aeruginosa  DNA,  which is  identical in 
density to  HSV,  was  added to  each density gradient.  The  results  of these 
experiments are shown in Fig. 4. The 3H-labeled  DNA prepared from both the 
lipopolysaccharide  (LPS)-and  HSV-stimulated  cultures  appear  identical  in D.  MOCHIZUKI,  S.  HEDRICK,  J.  WATSON,  AND  D.  T.  KINGSBURY  1503 
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FIG.  2.  The  kinetics  of  DNA  synthesis  after  the  addition  of  HSV-1  (Nii)  to  spleen 
cultures.  Spleen cultures were prepared from BALB/c mice and plated in microwells (10  ~ 
cells  in  0.2  ml  medium).  Either  10  ~ PFU  or  5  x  10  ~ PFU  HSV-1  (Nil)  was  added  to 
cultures.  After 24,  48,  or 72 h,  triplicate cultures were assayed for the incorporation of 
[3H]thymidine as described in the legend of Fig.  1. 
density  (p  =  1.700 g/cm  3)  to  mouse  DNA.  No  newly synthesized DNA  is 
observed co-sedimenting with the 32p-labeled P. aeruginosa DNA (p  =  1.728 g/ 
cm3). These data imply that most of the DNA synthesized after the addition of 
HSV to mouse spleen cultures is host cell and not viral in origin (Fig. 4). 
The Mitogenic Response Requires  Infectious  Virus.  A  number of agents 
have  been  found  to  be  specific  murine  B  lymphocyte mitogens  (15, 18). 
Therefore, it is necessary to show that the mitogenic properties of the HSV-1 
preparations are due to the virus, rather than a contaminant. Such a contami- 
nant could be LPS,  or something produced by the human diploid fibroblasts 
during the preparation of the HSV-1  stocks.  Since the  DNA synthesized in 
spleen cultures after addition of HSV is host rather than viral in origin, the 
mitogenic activity may be due to a viral protein, rather than the expression of 
the viral genome. 
B lymphocytes from C3H/HeJ mice are refractory to the mitogenic effects of 1504  MITOGENIC  RESPONSE  OF  MURINE  B  CELLS 
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FIG. 3.  Effect  of  HSV-1  on  DNA  synthesis  in  normal,  T-cell-depleted, macrophage- 
depleted,  and  thymocyte cultures.  The normal  spleen cultures  and  thymocyte cultures 
were prepared from BALB/c mice. The T cell-depleted cultures were prepared by using 
spleen cells from congenitally athymic (nude) mice, in which the genes responsible for the 
lack  of thymus  cells had  been bred  in  a  BALB/cbackground  (14). Triplicate cultures 
contained  10  e cells and  the  titers  of  HSV-1  (JH)  indicated.  After 48  h  the  uptake  of 
[3H]thymidine  into DNA was assayed as described in the legend of Fig. 1. 
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FIG. 4.  Cesium chloride  density  equilibrium  gradients  of  DNA  extracted  from LPS and 
HSV-1 (Nii)  stimulated BALB/c spleen cultures. Cells were labeled with [3H]thymidine as 
detailed in  the text.  As a density marker, 82p-labeled  P. aeruginosa DNA  (p = 1.728 g/cm  3) 
was added to each gradient before centrifugation. 
LPS  (15,  18).  The  data  presented  in  Fig.  5  show that two stocks  of HSV-1 
(Muckbeck and Nii) both stimulate DNA synthesis in C3H/HeJ spleen cultures. 
Thus, it is unlikely that LPS is responsible for the mitogenic activity of HSV. 
To distinguish between the requirement for infectious versus noninfectious 
virus for induction of DNA synthesis in B lymphocytes, we have made use of 
findings that heat and ultraviolet  (UV) treatments have been shown to have 
different effects on viral expression in other systems.  Heat treatment can be 
used  to  inactivate  HSV  by  preventing  adsorption  of HSV  to  the  cell.  UV 
treatment  leads  to  an  inhibition  of HSV  replication  in  human  fibroblast D.  MOCHIZUKI,  S.  HEDRICK,  J.  WATSON,  AND  D.  T.  KINGSBURY  1505 
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FIG.  5.  The stimulation  of DNA synthesis  by HSV-1  (Nii and  Muckbeck)  in C3H/HeJ 
spleen cultures.  Cells were prepared  and  assayed  as  described  in  the legend to Fig.  1. 
C3H/HeJ spleen cells do not support a mitegenic response to LPS (15,  18). 
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Fro.  6.  The  effect of infectious  HSV  and  heat-inactivated  HSV  on  DNA synthesis  in 
BALB/c spleen cultures.  Cells were cultured as described in the legend for Fig. 1. HSV-1 
(Nii and Muckbeck) were heat inactivated as detailed in Materials and Methods. 
cultures, but does not prevent the oncogenic potential of HSV  as shown by 
morphological transformation of cells in  culture,  or by tumor formation in 
animals (6-10). Heat treatment (56°C for 1 h) destroys the mitogenic properties 
of HSV-1.  The data for two virus stocks (Nii and Muckbeck) are described in 
Fig.  6.  The  effect  of  UV  treatment  on  the  infectious  activity  of HSV-1 
(Muckbeck) is  described in  the experiment of Fig.  7.  A  stock of virus was 
exposed to UV irradiation and at various periods, aliquots of a constant volume 
were assayed for PFU in human diploid fibroblasts. A decrease in virus titer is 
observed  with  increasing length  of UV  treatment  (Fig.  7).  The  mitogenic 
activity of UV-inactivated HSV-1  (Muckbeck) was then compared to that of 
nontreated infectious HSV-1 in mouse spleen cultures. The data are shown in 
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FIa.  7.  Kinetics  of inactivation of HSV-1  by  UV  irradiation.  A  virus  stock  of HSV-1 
(Muckbeck) suspended in complete MEM plus 5% FCS was exposed to UV light from an 
MR-4 lamp  (George Gates and Co.,  Long Island, N.Y.).  The virus suspension (2 ml) was 
placed in a 60-ram Petri dish and was slowly rotated throughout the irradiation period. At 
various intervals small samples were removed and the infectious titer determined by a 
standard plaque assay on diploid human fibroblasts. 
treated HSV-1.  The mitogenic response is plotted as a  function of the virus 
titer determined in the previous experiment (Fig. 7). The broken line represents 
the control,  which is the mitogenic response of spleen cultures to infectious 
HSV-1 (Muckbeck). This control virus stock was not UV treated, but added to 
cultures at corresponding PFU titers (Fig.  8). The mitogenic responses elicited 
by these two virus stocks are virtually identical when related to their infectious 
virus content. The mitogenic response is also proportional to the amount of 
infectious virus present, decreasing as the amount of infectious virus decreases 
(Fig.  8).  These experiments show that the  mitogenic response requires the 
presence of infectious HSV-1. 
We  have  also  prepared  a  stock  of HSV-1  which contains  predominantly 
defective virus particles. This is done by repeated high multiplicity infections 
of human diploid fibroblasts.  This virus  stock was not mitogenic in  mouse 
spleen cultures (data not shown). These experiments show that it is unlikely a D.  MOCHIZUKI,  S.  HEDRICK,  J.  WATSON,  AND  D.  T.  KINGSBURY 
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FIG. 8.  Dependence of mitogenic  activity  on the infectious  titer  of HSV.  Both UV 
irradiated  and  nonirradiated  HSV-1 (Muckbeck)  were  compared  for  their  mitegenic activity 
as a function of the infectious  virus titer.  In the case of the irradiated  virus,  the titer 
remaining in  the  undiluted suspension after  irradiation  was used  while, in  the case of  the 
control  virus,  the  stocks  were diluted  to  obtain the  necessary reduction in  infectious  titer. 
The cells  were cultured as described in the legend for Fig. 1. The labeling for all the 
cultures  was done after  48 h of  incubation ai~r infection.  The infectious  viral  titer  was 
determined  by plaque assays on low passage diploid  human fibroblasts. 
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viral protein is the mitogenic agent,  and confirm our previous findings that 
infectious HSV-1 is required for the mitogenic response. 
Discussion 
The addition of HSV-1 to mouse spleen cultures results in the induction of 
DNA  synthesis.  The  rate  of radioactive  thyrnidine incorporation reaches  a 
maximum 48  h  al~r  addition of virus to cultures,  and then decreases.  The 
stimulation observed is generally 10- to 50-fold above the background response, 
and is comparable in magnitude to the responses elicited by LPS in spleen 
cultures (Fig.  1). The DNA that is synthesized bands at a  density in cesium 
chloride which is characteristic of mouse cellular DNA (p  =  1.700 g/cm3), and 
not viral DNA (p =  1.728 g/cm  3) (Fig. 4). The stimulation of DNA synthesis by 
HSV-1  occurs in spleen cell cultures from congenitally athymic mice and in 
cultures which have been depleted of adherent cells by passage over Sephadex 
G-10, but not in thymocyte cultures (Fig. 3). In addition to the stimulation of 
radioactive thymidine incorporation which is the measure of cells synthesizing 
DNA, HSV-1 stimulates a polyclonal antibody response (Fig. 1). The magnitude 
of mitogenic and polyclonal responses induced by different concentrations of 
HSV-1 in culture are similar. These observations indicate that the B lympho- 
cytes in mouse spleen cultures are induced by HSV-1 to undergo DNA synthesis 
and differentiation to antibody-forming cells. 
Infectious HSV-1 appears to be the mitogenic agent. Heat treatment, which 1508  MITOGENIC  RESPONSE  OF  MURINE  B  CELLS 
prevents viral adsorption to the cell,  inactivates the mitegenic properties of 
HSV-1.  There was a  direct correlation in the loss of activity of HSV-1  when 
assayed for PFU in human diploid fibroblasts and for mitogenicity with murine 
lymphocytes, after UV irradiation (Figs.  7 and 8). These experiments directly 
implicate the expression of the HSV-1 genome in the initiation of the mitogenic 
process. Other possibilities as the causitive agents of mitogenesis, such as LPS, 
viral protein, or some nonspecific product of the human diploid fibroblasts used 
to prepare virus stocks, appear to be ruled out (Fig.  5). 
In view of the known oncogenic properties of HSV-1 (6-10, 19), it is of interest 
to question whether the viral DNA that induces the morphological transforma- 
tion of hamster and mouse fibroblasts in culture is responsible for the stimula- 
tion of DNA synthesis in B lymphocytes. Unless HSV-1 is UV-inactivated, it 
replicates in'fibroblasts and leads to cell destruction (6-10). Since infectious 
HSV-1 is required for the stimulation of B lymphocytes, it appears the response 
of fibroblasts and lymphocytes to HSV-1 differs. 
There have been two reports of successful in vitro transformation of tissue 
culture cells by infectious HSV. The first report (20) demonstrated the morpho- 
logical  transformation  of human  embryonic lung  cells.  The  second  report 
showed that the XC cell line (21), a rat fibroblast line carrying a Rous sarcoma 
virus genome, was biochemically transformed by HSV in the absence of viral 
inactivation (21). Unfortunately, neither of these reports have been confirmed. 
If the transforming region of the HSV-1 genome is responsible for the observed 
mitogenicity in murine B lymphocytes, HSV-1 may be capable of transforming 
B lymphocytes into malignant cells. However, proof that transformation has 
occurred requires either establishment of continuous cell lines or, growth as a 
malignant tumor in syngeneic recipients. If malignancy is demonstrated, then 
the possibility  exists that the B-cell  tumors produced would be found to be 
plasmacytomas. 
Spleen cell cultures infected with HSV-1  do not appear to synthesize viral 
DNA (Fig.  4). This means that if viral replication is required for mitogenesis, 
it must be very low. In a later report, we will show that infectious HSV-1 is not 
produced  in  lymphocyte cultures  after  the  mitogenic response  induced  by 
HSV-1. 2 These observations are in agreement with those of Kirchner et al. (22, 
23), who have shown that HSV is mitogenic in mouse spleen cultures, and that 
HSV  replication can only be  demonstrated in mouse spleen cultures which 
have been prestimulated with LPS or Poly I:C for 48 h before infection. Every 
strain tested appeared to be permissive for viral replication except C57BL/6 
mice. This observation awaits confirmation, however, it presents an interesting 
way of studying the host control of HSV infection. By using genetic analyses of 
a  permissive  and  nonpermissive host,  our  studies  may provide  a  basis  for 
probing  the  complex regulation  of the  expression  of the  HSV  genome  in 
eukaryotic cells. 
Summary 
Herpes  simplex  virus  (HSV)  stimulates  DNA  synthesis  in  mouse  spleen 
2 S.  Hedrick,  D.  T.  Kingsbury,  and J.  Watson. The Interaction of herpes simplex virus with 
murine lymphocytes. II. Kinetics of the host cell response, and virus replication. Manuscript in 
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cultures prepared from normal,  macrophage-depldted,  and T-cell-depleted 
spleen cells,  but not from thymocytes. In addition, a polyclonal antibody 
response is observed in HSV-infected spleen cultures.  These findings  indicate 
that  the cells  stimulated to  undergo DNA  synthesis  after  HSV infection  appear 
to be the bone marrow-derived lyrnphocytes.  The newly synthesized DNA  is 
host cell  and not of  viral  origin.  Heat treatment and ultraviolet  irradiation  of 
HSV before  addition  to  spleen  cultures  prevents  the  induction  of  DNA synthesis. 
We consider  the use of  this  system as assay for  the study  of  cell  transformation 
by HSV and also  for  the study  of  host  cell  control  of  the expression  of  the viral 
genome. 
Received for publication 28 July 1977. 
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